4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-23-038945
Chief Executive Officer sold 75,810 shares at an average $17.12 ($1,297,542)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd Chief Executive Officer | 2023-06-16 | Sale 10b5-1 | −3,316 | $16.49 | $54,681 | 1,697,960 | D |
| Harris Todd Chief Executive Officer | 2023-06-16 | Sale 10b5-1 | −50,838 | $17.06 | $867,296 | 1,647,122 | D |
| Harris Todd Chief Executive Officer | 2023-06-16 | Sale 10b5-1 | −600 | $18.50 | $11,100 | 1,646,522 | D |
| Harris Todd Chief Executive Officer | 2023-06-20 | Sale 10b5-1 | −1,300 | $16.53 | $21,493 | 1,645,222 | D |
| Harris Todd Chief Executive Officer | 2023-06-21 | Sale 10b5-1 | −4,629 | $16.12 | $74,615 | 1,640,593 | D |
| Harris Todd Chief Executive Officer | 2023-06-21 | Sale 10b5-1 | −14,027 | $17.71 | $248,358 | 1,626,566 | D |
| Harris Todd Chief Executive Officer | 2023-06-21 | Sale 10b5-1 | −1,100 | $18.18 | $19,999 | 1,625,466 | D |
| Open-market sales · 75,810 sh · avg $17.12 · $1,297,542 | |||||||
Loading xslF345X04/doc4.xml…